Thermoradiotherapy-Driven Enhancement of Cuproptosis by Copper-Nitroimidazole Based Nanoparticles

Read full text
Authors: Yang D, Tao L, Li Q, Ning S, Song Y
Cited by: 0

Abstract

Deyi Yang,1,* Lin Tao,2,* Qi Li,2,3 Shipeng Ning,2,3 Yanni Song1 1Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, People’s Republic of China; 2Research Center of Nanomedicine Technology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, People’s Republic of China; 3Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shipeng Ning, Email nspdoctor@sr.gxmu.edu.cn Yanni Song, Email 1525@hrbmu.edu.cnIntroduction: Cuproptosis, a novel form of cell death tied to copper homeostasis and protein lipoylation, holds significant promise for breast cancer treatment. However, its efficacy is severely hindered by the tumor microenvironment (TME) heterogeneity, such as hypoxia and elevated glutathione (GSH) levels.Methods: Herein, we synthesized CuNI nanoparticles via a facile hydrothermal method, which could serve as both a copper carrier and a photothermal agent, to enhance the accumulation of copper in tumor site. Following intravenous injection, CuNI accumulated and persisted in tumors via the enhanced permeability and retention effect (EPR) effect. Subsequent gradient 808 nm laser irradiation and radiotherapy (RT) were administered, CuNI could convert light energy to heat energy, which could alleviate hypoxia TME, while RT further depleted GSH and synergistically generates reactive oxygen species (ROS) with CuNI, synergistically amplifying CuNi-mediated cuproptosis.Results: This co-treatment triggered immunogenic cell death (ICD), activating dendritic cells and T-cell responses to reverse the “cold” immune microenvironment. In vivo studies demonstrated complete tumor suppression with no overt toxicity.Conclusion: The CuNI + NIR + RT strategy, leveraging “cuproptosis/ICD synergy”, offers a novel paradigm for the clinical translation of cuproptosis in breast cancer.Keywords: cuproptosis, radiotherapy, photothermal therapy, immunogenic cell death

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Radiation Therapy and Dosimetry Nanoparticle-Based Drug Delivery

Publication details

Journal / source
DOAJ (DOAJ: Directory of Open Access Journals)
Publication date
1 January 2026
Language
EN